SCHEMBL24850751

SCHEMBL24850751

CC(=O)N[C@H](C(=O)C(C)(C)C)C(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADAM17 P78536 1/20 0.36
DPP4 P27487 1/20 0.36
DPP8 Q6V1X1 1/20 0.36
DPP9 Q86TI2 1/20 0.36
ELANE P08246 2/20 0.33
ALDH1A1 P00352 1/20 0.33
MEN1 O00255 4/20 0.33
KMT2A Q03164 4/20 0.33
CTSS P25774 1/20 0.31
CTSK P43235 1/20 0.31
SMN1; SMN2 Q16637 4/20 0.30
POLB P06746 2/20 0.30
KDM4E B2RXH2 1/20 0.30
MAPT P10636 1/20 0.30
THRB P10828 1/20 0.30
ALOX15 P16050 1/20 0.30
NFKB1 P19838 1/20 0.30
PTGS2 P35354 1/20 0.30
THPO P40225 1/20 0.30
RECQL P46063 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13543178 0.84 ADAM17 (0.33) ADAM17ALDH1A1
SCHEMBL24909282 0.84 ADAM17 (0.36) ADAM17DPP4DPP8DPP9ELANE
SCHEMBL24263338 0.82 L3MBTL1 (0.37) ELANEALDH1A1MEN1KMT2ACTSS
SCHEMBL22600649 0.82 L3MBTL1 (0.37) ELANEALDH1A1MEN1KMT2ACTSS
SCHEMBL18462937 0.80 CTSS (0.33) DPP4ALDH1A1CTSSCTSKSMN1; SMN2
SCHEMBL7292999 0.80 ELANE (0.44) DPP4DPP8DPP9ELANE
SCHEMBL8746308 0.78 ELANE (0.43) DPP4DPP8DPP9ELANE
Hydrochloric Acid SCHEMBL7303909 0.78 ELANE (0.43) DPP4DPP8DPP9ELANE
SCHEMBL12413541 0.78 ALDH1A1 (0.44) ALDH1A1MEN1KMT2ASMN1; SMN2POLB
SCHEMBL13684409 0.78 ALDH1A1 (0.44) ALDH1A1MEN1KMT2ASMN1; SMN2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230025932-A1 NOVEL FUNCTIONALIZED LACTONES AS MODULATORS OF THE 5-HYDROXYTRYPTAMINE RECEPTOR 7 AND THEIR METHOD OF USE PRAEVENTIX, LLC 2023-01-26 US disclosed
US-20230002383-A1 NOVEL FUNCTIONALIZED LACTAMS AS MODULATORS OF THE 5-HYDROXYTRYPTAMINE RECEPTOR 7 AND THEIR METHOD OF USE PRAEVENTIX, LLC 2023-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230025932-A1 NOVEL FUNCTIONALIZED LACTONES AS MODULATORS OF THE 5-HYDROXYTRYPTAMINE RECEPTOR 7 AND THEIR METHOD OF USE HTR7, HTR2C, HTR3A ADAM17 1736/4885DPP4 3292/4885DPP8 1765/4885
US-20230002383-A1 NOVEL FUNCTIONALIZED LACTAMS AS MODULATORS OF THE 5-HYDROXYTRYPTAMINE RECEPTOR 7 AND THEIR METHOD OF USE HTR7, HTR1A, HTR2C ADAM17 1245/4885DPP4 2741/4885DPP8 1234/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.